U.S. patent law will have to adapt to the use of AI in the life sciences industry.
Justin T. Fleischacker
Advertisement
Articles by Justin T. Fleischacker
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
2
FDA Approves Bayer’s Lynkuet as First Dual Neurokinin Antagonist for Menopausal Hot Flashes
3
FDA Approves Blenrep for Treatment of Replapsed/Refractory Multiple Myeloma
4
Lilly Enters Definitive Agreement Acquiring Aderum Biotechnologies
5
